PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) will participate in the Piper Sandler Virtual CNS Symposium on Thursday, Aug. 13, giving investors an opportunity to hear from management as the pharmaceutical company advances its rare neurological disease business.
Harmony’s management team is scheduled to participate in a fireside chat at 1:30 p.m. ET, according to the company. The event will be held virtually.
A webcast of the fireside chat will be available through Harmony’s investor relations website: https://ir.harmonybiosciences.com/
Harmony, headquartered in Plymouth Meeting, develops and commercializes therapies for rare neurological diseases. The company was established by Paragon Biosciences LLC in 2017.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.